WO2014104989A8 - Pharmaceutical compositions comprising aripiprazole - Google Patents
Pharmaceutical compositions comprising aripiprazole Download PDFInfo
- Publication number
- WO2014104989A8 WO2014104989A8 PCT/TR2012/000232 TR2012000232W WO2014104989A8 WO 2014104989 A8 WO2014104989 A8 WO 2014104989A8 TR 2012000232 W TR2012000232 W TR 2012000232W WO 2014104989 A8 WO2014104989 A8 WO 2014104989A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- aripiprazole
- pharmaceutical compositions
- disorder
- schizophrenia
- shall
- Prior art date
Links
- CEUORZQYGODEFX-UHFFFAOYSA-N Aripirazole Chemical compound ClC1=CC=CC(N2CCN(CCCCOC=3C=C4NC(=O)CCC4=CC=3)CC2)=C1Cl CEUORZQYGODEFX-UHFFFAOYSA-N 0.000 title abstract 2
- 229960004372 aripiprazole Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 208000020706 Autistic disease Diseases 0.000 abstract 1
- 208000020925 Bipolar disease Diseases 0.000 abstract 1
- 206010022998 Irritability Diseases 0.000 abstract 1
- 208000024714 major depressive disease Diseases 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to pharmaceutical formulations comprising aripiprazole that shall be used in treatment of irritability associated with schizophrenia, bipolar disorder, major depression, autistic disorder.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR201112993 | 2011-12-27 | ||
TR2011/12993 | 2011-12-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2014104989A1 WO2014104989A1 (en) | 2014-07-03 |
WO2014104989A8 true WO2014104989A8 (en) | 2014-08-14 |
Family
ID=47684008
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/TR2012/000232 WO2014104989A1 (en) | 2011-12-27 | 2012-12-27 | Pharmaceutical compositions comprising aripiprazole |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2014104989A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI594765B (en) * | 2012-04-30 | 2017-08-11 | 大塚製藥股份有限公司 | Oral formulation |
JP2019515032A (en) * | 2016-04-25 | 2019-06-06 | 大塚製薬株式会社 | Composition of pharmaceutical product having ingestible event marker |
IT201900020350A1 (en) * | 2019-11-05 | 2021-05-05 | Alpex Pharma Sa | Vardenafil orodispersible formulation |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5006528A (en) | 1988-10-31 | 1991-04-09 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
TWI324074B (en) * | 2001-10-09 | 2010-05-01 | Bristol Myers Squibb Co | Flashmelt oral dosage formulation |
CA2600542A1 (en) * | 2005-03-17 | 2006-09-21 | Synthon B.V. | Pharmaceutical tablets of crystalline type ii aripiprazole |
EP1808164B2 (en) * | 2006-01-05 | 2018-07-04 | Teva Pharmaceutical Industries Ltd | Wet granulation method for preparing pharmaceutical compositions of aripiprazole |
TR200604349A2 (en) * | 2006-08-15 | 2008-03-21 | NOBEL İLAÇ SANAYii VE TiCARET A.Ş. | Pharmaceutical compositions containing aripiprazole |
SI2081904T1 (en) * | 2006-09-22 | 2011-05-31 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Aripiprazole hemifumarate and process for its preparation |
WO2010079506A2 (en) * | 2008-06-23 | 2010-07-15 | Torrent Pharmaceuticals Ltd. | Pharmaceutical composition of aripiprazole |
US20120214820A1 (en) * | 2009-09-15 | 2012-08-23 | Ratiopharm Gmbh | Orally disintegrating pharmaceutical dosage form containing aripiprazole |
TR201000948A1 (en) * | 2010-02-09 | 2011-08-22 | Sanovel İlaç San.Ve Ti̇c.A.Ş. | Aripiprazole formulations. |
DE102010019416A1 (en) * | 2010-05-04 | 2011-11-10 | Stada Arzneimittel Ag | Orodispersible tablet comprising a triptan or an atypical neuroleptic |
-
2012
- 2012-12-27 WO PCT/TR2012/000232 patent/WO2014104989A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2014104989A1 (en) | 2014-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12014501738A1 (en) | Piperidino-pyrimidine derivatives for the treatment of viral infections | |
PH12015500274B1 (en) | Alkylpyrimidine derivatives for the treatment of viral infections and further diseases | |
IN2014DN09434A (en) | ||
WO2013151736A3 (en) | In vivo production of proteins | |
PH12014501702A1 (en) | Imidazopyrrolidinone compounds | |
PH12015500850A1 (en) | Stable preservative-free mydriatic and anti-inflammatory solutions for injection | |
GB201209613D0 (en) | New compounds | |
IN2015DN03327A (en) | ||
MX366899B (en) | New compounds. | |
PH12014501991B1 (en) | Phenicol antibacterials | |
EP2931288A4 (en) | Topical formulations for increasing the dermal concentration of hyaluronic acid | |
IN2015KN00005A (en) | ||
WO2014057362A3 (en) | Omega -3 compositions | |
GB2502032A (en) | Vitamin D composition | |
IN2014DN06104A (en) | ||
MX2013013649A (en) | Quinone compounds for treating ape1 mediated diseases. | |
TR201910866T4 (en) | Combined preparations for cancer treatment. | |
EP2931310A4 (en) | Compositions, methods of administration and uses for trivalent dengue virus formulations | |
MX366829B (en) | Itraconazole compositions and dosage forms, and methods of using the same. | |
WO2014104989A8 (en) | Pharmaceutical compositions comprising aripiprazole | |
MX355719B (en) | Pharmaceutical composition in the form of an oral suspension including a flavonoid fraction and xanthan gum. | |
UA117567C2 (en) | Galactagogue compositions based on phosphatidylserine | |
MX2014006574A (en) | Acamprosate formulations, methods of using the same, and combinations comprising the same. | |
MX2014006201A (en) | Imatinib solid dosage forms reconstituted just before use. | |
NZ629475A (en) | Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12823177 Country of ref document: EP Kind code of ref document: A1 |
|
122 | Ep: pct app. not ent. europ. phase |
Ref document number: 12823177 Country of ref document: EP Kind code of ref document: A1 |